Title: Brooklyn Investment Group Cuts Colgate Stake
Byline: Based on a story in Watch List News published on 2025-08-19 13:58:45
Excerpt: Brooklyn Investment Group trimmed its stake in Colgate-Palmolive by 9.5 percent in the first quarter, selling 529 shares. The sale leaves the fund with 5,035 shares valued at roughly $472,000, according to portfolio tracker Holdings Channel.
Key Takeaways:
- Brooklyn Investment Group reduced its Colgate-Palmolive holding by 9.5 percent.
- The fund sold 529 shares during the first quarter.
- It now owns 5,035 Colgate-Palmolive shares.
- The remaining position is valued at about $472,000.
Inside a Measured Portfolio Move
Brooklyn Investment Group has pared back—though not abandoned—its exposure to consumer-products stalwart Colgate-Palmolive. Data compiled by Holdings Channel show the fund sold 529 shares during the first quarter, a move that cut its stake by 9.5 percent.
The Numbers
At quarter’s end the fund’s position stood at 5,035 shares, worth an estimated $472,000. A simple before-and-after snapshot illustrates the trimming:
| | Share Count | |—————–|————-| | Before sale* | 5,564 | | Shares sold | –529 | | After sale | 5,035 |
*Calculated by adding the 529 shares sold to the quarter-end total.
Why It Matters
“Brooklyn Investment Group lessened its stake … by 9.5 % during the 1st quarter,” the filing summary notes—evidence of incremental portfolio management rather than a sweeping exit. For investors tracking institutional sentiment, even modest changes can signal shifting risk tolerance or a routine rebalance.
Still in the Game
With roughly half a million dollars still invested, the fund retains meaningful exposure to Colgate-Palmolive. Whether future quarters bring further reductions or renewed buying will be watched closely, but for now the move marks a slight recalibration rather than a retreat.
Source and Method
All figures come from Holdings Channel data cited by Watch List News.
